Company: SLNH
Filing Date: 2025-01-15
Form Type: CORRESP
Source: 0001493152-25-002392
Chunk: 0

Company: Soluna Holdings, Inc
Filing Date: 2025-01-15
Form: CORRESP
Chunk 0
---
| Daniel    
 L. Forman 
 Partner   |                          | 1251                   
 Avenue of the Americas 
 New                    
 York, New York 10020   |
|           | T:                       
 (212) 419-5904           
 E:dforman@lowenstein.com |                        |

January 15, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Jessica Livingston, David Lin

| Re: | Soluna                                          
 Holdings, Inc.                                  
 Amendment                                       
 No. 2 to the Registration Statement on Form S-1 
 Filed                                           
 December 16, 2024                               |
|:----|:------------------------------------------------|
|     | File                                            
 No. 333-282559                                  |

Ladies and Gentlemen:

On behalf of Soluna Holdings, Inc. (the “ Company”), we are submitting this letter to the Securities and Exchange Commission (the “ SEC”) via EDGAR in response to the comment letter from the staff of the SEC (the “ Staff”), dated January 14, 2025 (the “ Comment Letter”), pertaining to the Company’s above-referenced Amendment No. 2 to the Registration Statement on Form S-1 filed on December 16, 2024. In connection with such responses, the Company is concurrently filing an Amendment No. 3 to the Registration Statement (the “ Amended Registration Statement”). Capitalized terms used but not defined in this letter have the meaning given in the Amended Registration Statement.

To assist your review, we have reproduced the text of the Staff’s comments in italics below, followed by responses on behalf of the Company.

Amendment No. 2 to Registration Statement on Form S-1 filed December 16, 2024

General

| 1. | We                                                                                                                                   
 note that you are registering, among others, the resale of 140,000 shares of common stock issuable upon the exercise of the warrants 
 (the “Warrants”) issued to the Series B Holder on October 1, 2024, pursuant to the waiver it granted the company in connection       
 with the SEPA. Please file as exhibits to the registration statement (i) the Waiver Agreement, dated October 1, 2024, between the    
 Company and the Series B Holder, as referenced in your response to prior comment 3, and (ii) the form of Warrant